What the Research Says
Vitamin B3 has a complex clinical profile. For cholesterol, niacin was a cornerstone therapy for decades, but the AIM-HIGH trial (2011, n=3,414) found no cardiovascular benefit when added to statin therapy, diminishing enthusiasm for high-dose niacin. For skin health, the ONTRAC trial by Chen et al. (2015, n=386) demonstrated that nicotinamide 500 mg twice daily reduced the incidence of new non-melanoma skin cancers by 23%. In aging research, Martens et al. (2018) showed that nicotinamide riboside (NR) at 1,000 mg/day raised NAD+ levels by approximately 60% and was well-tolerated in healthy older adults, though clinical outcome benefits remain under investigation.
